POZEN Logo
Print Page   Close Window

Press Release

POZEN to Present at the Ladenburg Thalmann Healthcare Conference

CHAPEL HILL, N.C.--(BUSINESS WIRE)--Sep. 15, 2015-- POZEN Inc. (NASDAQ: POZN), a specialty pharmaceutical company, today announced that certain members of the executive management team will participate in the Ladenburg Thalmann Healthcare Conference to be held September 29, 2015 in New York. Adrian Adams, Chief Executive Officer, is scheduled to present an overview of the Company at 3:00 p.m. ET on Tuesday, September 29, 2015.

The presentation will also be webcast on the POZEN website under the “Events” section on September 29, 2015. To access the live webcast, please log on to POZEN’s site approximately 15 minutes prior to the presentation to register and download any necessary audio software. The presentation replay will be available for 90 days after the event.

About POZEN

POZEN Inc. is a specialty pharmaceutical company that to date has historically focused on developing novel therapeutics for unmet medical needs and licensing those products to other pharmaceutical companies for commercialization. By utilizing a unique in-source model and focusing on integrated therapies, POZEN has successfully developed and obtained FDA approval of two self-invented products. Funded by these milestones/royalty streams, POZEN has created a portfolio of cost-effective, evidence-based integrated aspirin therapies designed to enable the full power of aspirin by reducing its GI damage.

POZEN’s common stock is traded under the symbol “POZN” on The NASDAQ Global Market. For more detailed company information, including copies of this and other press releases, please visit www.POZEN.com.

Source: POZEN Inc.

POZEN Inc.
Bill Hodges, 919-913-1030
Chief Financial Officer
or
Nichol Ochsner, 919-913-1030
Executive Director, Investor Relations & Corporate Communications